GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » ROE % Adjusted to Book Value

PTHL (Pheton Holdings) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings ROE % Adjusted to Book Value?

Pheton Holdings's ROE % for the quarter that ended in Jun. 2024 was -354.04%. Pheton Holdings's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Pheton Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Pheton Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Pheton Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings ROE % Adjusted to Book Value Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Pheton Holdings's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Pheton Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pheton Holdings's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pheton Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pheton Holdings's ROE % Adjusted to Book Value falls into.


Pheton Holdings ROE % Adjusted to Book Value Calculation

Pheton Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-55.92% / N/A
=N/A

Pheton Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-354.04% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pheton Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pheton Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pheton Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Website
http://www.ftzy.com.cn
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines

From GuruFocus

Pheton Holdings Ltd Announces Pricing of Initial Public Offering

By Marketwired • 09-05-2024

Pheton Holdings Ltd Announces Closing of Initial Public Offering

By Marketwired • 09-06-2024